Warning letterFDA · Sep 7, 2017
Newton Everett/WR Group Inc. 9/7/17
Named company: Newton Everett/WR Group Inc.
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your products fail to bear adequate…
Lot information: not specified in this record.